1	EG&G	_	NNP	_	_	3	SBJ	_	_
2	Inc.	_	NNP	_	_	1	POSTHON	_	_
3	said	_	VBD	_	_	0	ROOT	_	_
4	it	_	PRP	_	_	5	SBJ	_	_
5	acquired	_	VBD	_	_	3	OBJ	_	_
6	Laboratorium	_	NNP	_	_	9	NAME	_	_
7	Prof.	_	NNP	_	_	9	NAME	_	_
8	Dr.	_	NNP	_	_	9	NAME	_	_
9	Berthold	_	NNP	_	_	5	OBJ	_	_
10	,	_	,	_	_	9	P	_	_
11	a	_	DT	_	_	13	NMOD	_	_
12	German	_	JJ	_	_	13	NMOD	_	_
13	maker	_	NN	_	_	9	APPO	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	scientific	_	JJ	_	_	16	NMOD	_	_
16	instruments	_	NNS	_	_	14	PMOD	_	_
17	.	_	.	_	_	3	P	_	_

1	Terms	_	NNS	_	_	2	SBJ	_	_
2	were	_	VBD	_	_	0	ROOT	_	_
3	n't	_	RB	_	_	2	ADV	_	_
4	disclosed	_	VBN	_	_	2	VC	_	_
5	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	6	NMOD	_	_
2	Wellesley	_	NNP	_	_	4	NAME	_	_
3	,	_	,	_	_	4	P	_	_
4	Mass.	_	NNP	_	_	6	LOC	_	_
5	,	_	,	_	_	4	P	_	_
6	maker	_	NN	_	_	13	SBJ	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	scientific	_	JJ	_	_	9	NMOD	_	_
9	instruments	_	NNS	_	_	7	PMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	electronic	_	JJ	_	_	12	NMOD	_	_
12	parts	_	NNS	_	_	10	CONJ	_	_
13	said	_	VBD	_	_	0	ROOT	_	_
14	Berthold	_	NNP	_	_	15	SBJ	_	_
15	expects	_	VBZ	_	_	13	OBJ	_	_
16	1989	_	CD	_	_	17	NMOD	_	_
17	sales	_	NNS	_	_	15	OBJ	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	more	_	JJR	_	_	22	DEP	_	_
20	than	_	IN	_	_	22	DEP	_	_
21	100	_	CD	_	_	22	DEP	_	_
22	million	_	CD	_	_	24	NMOD	_	_
23	Deutsche	_	FW	_	_	24	NMOD	_	_
24	marks	_	NNS	_	_	18	PMOD	_	_
25	(	_	(	_	_	26	P	_	_
26	$	_	$	_	_	24	PRN	_	_
27	54.5	_	CD	_	_	26	DEP	_	_
28	million	_	CD	_	_	26	DEP	_	_
29	)	_	)	_	_	26	P	_	_
30	and	_	CC	_	_	15	COORD	_	_
31	employs	_	VBZ	_	_	30	CONJ	_	_
32	about	_	IN	_	_	33	DEP	_	_
33	400	_	CD	_	_	34	NMOD	_	_
34	people	_	NNS	_	_	31	OBJ	_	_
35	.	_	.	_	_	13	P	_	_

1	Berthold	_	NNP	_	_	2	SBJ	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	based	_	VBN	_	_	2	VC	_	_
4	in	_	IN	_	_	3	LOC	_	_
5	Wildbad	_	NNP	_	_	4	PMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	West	_	NNP	_	_	8	NAME	_	_
8	Germany	_	NNP	_	_	5	APPO	_	_
9	,	_	,	_	_	5	P	_	_
10	and	_	CC	_	_	2	COORD	_	_
11	also	_	RB	_	_	12	ADV	_	_
12	has	_	VBZ	_	_	10	CONJ	_	_
13	operations	_	NNS	_	_	12	OBJ	_	_
14	in	_	IN	_	_	13	LOC	_	_
15	Belgium	_	NNP	_	_	14	PMOD	_	_
16	.	_	.	_	_	2	P	_	_

1	John	_	NNP	_	_	3	NAME	_	_
2	M.	_	NNP	_	_	3	NAME	_	_
3	Kucharski	_	NNP	_	_	12	SBJ	_	_
4	,	_	,	_	_	3	P	_	_
5	EG&G	_	NNP	_	_	7	NMOD	_	_
6	's	_	POS	_	_	5	SUFFIX	_	_
7	chairman	_	NN	_	_	3	APPO	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	chief	_	JJ	_	_	10	NMOD	_	_
10	executive	_	NN	_	_	8	CONJ	_	_
11	,	_	,	_	_	3	P	_	_
12	said	_	VBD	_	_	0	ROOT	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	acquisition	_	NN	_	_	16	SBJ	_	_
15	``	_	``	_	_	16	P	_	_
16	will	_	MD	_	_	12	OBJ	_	_
17	extend	_	VB	_	_	16	VC	_	_
18	EG&G	_	NNP	_	_	21	NMOD	_	_
19	's	_	POS	_	_	18	SUFFIX	_	_
20	core	_	NN	_	_	21	NMOD	_	_
21	technologies	_	NNS	_	_	17	OBJ	_	_
22	,	_	,	_	_	17	P	_	_
23	strengthen	_	VB	_	_	17	COORD	_	_
24	its	_	PRP$	_	_	25	NMOD	_	_
25	position	_	NN	_	_	23	OBJ	_	_
26	in	_	IN	_	_	25	LOC	_	_
27	the	_	DT	_	_	30	NMOD	_	_
28	European	_	NNP	_	_	30	NAME	_	_
29	Economic	_	NNP	_	_	30	NAME	_	_
30	Community	_	NNP	_	_	26	PMOD	_	_
31	and	_	CC	_	_	23	COORD	_	_
32	assure	_	VB	_	_	31	CONJ	_	_
33	a	_	DT	_	_	34	NMOD	_	_
34	strength	_	NN	_	_	32	OBJ	_	_
35	and	_	CC	_	_	34	COORD	_	_
36	presence	_	NN	_	_	35	CONJ	_	_
37	in	_	IN	_	_	34	LOC	_	_
38	the	_	DT	_	_	41	NMOD	_	_
39	Eastern	_	JJ	_	_	41	NMOD	_	_
40	European	_	JJ	_	_	41	NMOD	_	_
41	market	_	NN	_	_	37	PMOD	_	_
42	.	_	.	_	_	12	P	_	_
43	''	_	''	_	_	12	P	_	_

1	He	_	PRP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	it	_	PRP	_	_	5	SBJ	_	_
4	especially	_	RB	_	_	5	ADV	_	_
5	will	_	MD	_	_	2	OBJ	_	_
6	strengthen	_	VB	_	_	5	VC	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	company	_	NN	_	_	10	NMOD	_	_
9	's	_	POS	_	_	8	SUFFIX	_	_
10	efforts	_	NNS	_	_	6	OBJ	_	_
11	in	_	IN	_	_	10	LOC	_	_
12	the	_	DT	_	_	15	NMOD	_	_
13	rapidly	_	RB	_	_	14	AMOD	_	_
14	growing	_	VBG	_	_	15	NMOD	_	_
15	field	_	NN	_	_	11	PMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	bio-analytical	_	JJ	_	_	18	NMOD	_	_
18	instrumentation	_	NN	_	_	16	PMOD	_	_
19	,	_	,	_	_	11	P	_	_
20	and	_	CC	_	_	11	COORD	_	_
21	in	_	IN	_	_	20	CONJ	_	_
22	applied	_	JJ	_	_	24	NMOD	_	_
23	nuclear	_	JJ	_	_	24	NMOD	_	_
24	physics	_	NNS	_	_	21	PMOD	_	_
25	.	_	.	_	_	2	P	_	_

1	Separately	_	RB	_	_	4	ADV	_	_
2	,	_	,	_	_	4	P	_	_
3	EG&G	_	NNP	_	_	4	SBJ	_	_
4	said	_	VBD	_	_	0	ROOT	_	_
5	it	_	PRP	_	_	6	SBJ	_	_
6	sold	_	VBD	_	_	4	OBJ	_	_
7	most	_	JJS	_	_	6	OBJ	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	its	_	PRP$	_	_	13	NMOD	_	_
10	Mason	_	NNP	_	_	13	NMOD	_	_
11	Research	_	NNP	_	_	13	NMOD	_	_
12	Institute	_	NNP	_	_	13	NMOD	_	_
13	subsidiary	_	NN	_	_	8	PMOD	_	_
14	to	_	TO	_	_	6	DTV	_	_
15	Transgenic	_	NNP	_	_	16	NAME	_	_
16	Sciences	_	NNPS	_	_	14	PMOD	_	_
17	Inc.	_	NNP	_	_	16	POSTHON	_	_
18	,	_	,	_	_	16	P	_	_
19	a	_	DT	_	_	23	NMOD	_	_
20	closely	_	RB	_	_	21	AMOD	_	_
21	held	_	JJ	_	_	23	NMOD	_	_
22	biotechnology	_	NN	_	_	23	NMOD	_	_
23	company	_	NN	_	_	16	APPO	_	_
24	based	_	VBN	_	_	23	APPO	_	_
25	in	_	IN	_	_	24	LOC	_	_
26	Worcester	_	NNP	_	_	25	PMOD	_	_
27	,	_	,	_	_	26	P	_	_
28	Mass	_	NNP	_	_	26	APPO	_	_
29	.	_	.	_	_	4	P	_	_

1	The	_	DT	_	_	2	NMOD	_	_
2	sale	_	NN	_	_	13	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	for	_	IN	_	_	2	NMOD	_	_
5	$	_	$	_	_	4	PMOD	_	_
6	7	_	CD	_	_	5	DEP	_	_
7	million	_	CD	_	_	5	DEP	_	_
8	in	_	IN	_	_	5	NMOD	_	_
9	cash	_	NN	_	_	8	PMOD	_	_
10	and	_	CC	_	_	9	COORD	_	_
11	securities	_	NNS	_	_	10	CONJ	_	_
12	,	_	,	_	_	2	P	_	_
13	will	_	MD	_	_	25	OBJ	_	_
14	leave	_	VB	_	_	13	VC	_	_
15	EG&G	_	NNP	_	_	14	OBJ	_	_
16	with	_	IN	_	_	14	ADV	_	_
17	a	_	DT	_	_	20	NMOD	_	_
18	12	_	CD	_	_	19	AMOD	_	_
19	%	_	NN	_	_	20	NMOD	_	_
20	stake	_	NN	_	_	16	PMOD	_	_
21	in	_	IN	_	_	20	NMOD	_	_
22	Transgenic	_	NNP	_	_	21	PMOD	_	_
23	,	_	,	_	_	25	P	_	_
24	executives	_	NNS	_	_	25	SBJ	_	_
25	said	_	VBD	_	_	0	ROOT	_	_
26	.	_	.	_	_	25	P	_	_

1	Mason	_	NNP	_	_	2	SBJ	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	the	_	DT	_	_	6	NMOD	_	_
4	largest	_	JJS	_	_	6	NMOD	_	_
5	toxicology	_	NN	_	_	6	NMOD	_	_
6	lab	_	NN	_	_	2	PRD	_	_
7	in	_	IN	_	_	6	LOC	_	_
8	New	_	NNP	_	_	9	NAME	_	_
9	England	_	NNP	_	_	7	PMOD	_	_
10	,	_	,	_	_	2	P	_	_
11	with	_	IN	_	_	2	ADV	_	_
12	annual	_	JJ	_	_	13	NMOD	_	_
13	revenue	_	NN	_	_	11	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	$	_	$	_	_	14	PMOD	_	_
16	8	_	CD	_	_	15	DEP	_	_
17	million	_	CD	_	_	15	DEP	_	_
18	and	_	CC	_	_	13	COORD	_	_
19	140	_	CD	_	_	20	NMOD	_	_
20	employees	_	NNS	_	_	18	CONJ	_	_
21	.	_	.	_	_	2	P	_	_

1	Mason	_	NNP	_	_	2	SBJ	_	_
2	serves	_	VBZ	_	_	0	ROOT	_	_
3	commercial	_	JJ	_	_	2	OBJ	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	government	_	NN	_	_	6	NMOD	_	_
6	customers	_	NNS	_	_	4	CONJ	_	_
7	,	_	,	_	_	3	P	_	_
8	including	_	VBG	_	_	3	NMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	National	_	NNP	_	_	11	NAME	_	_
11	Institutes	_	NNPS	_	_	8	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	Health	_	NNP	_	_	12	PMOD	_	_
14	.	_	.	_	_	2	P	_	_

1	The	_	DT	_	_	3	NMOD	_	_
2	combined	_	JJ	_	_	3	NMOD	_	_
3	companies	_	NNS	_	_	4	SBJ	_	_
4	will	_	MD	_	_	11	OBJ	_	_
5	become	_	VB	_	_	4	VC	_	_
6	profitable	_	JJ	_	_	5	PRD	_	_
7	by	_	IN	_	_	5	TMP	_	_
8	January	_	NNP	_	_	7	PMOD	_	_
9	1990	_	CD	_	_	8	NMOD	_	_
10	,	_	,	_	_	11	P	_	_
11	said	_	VBD	_	_	0	ROOT	_	_
12	James	_	NNP	_	_	14	NAME	_	_
13	P.	_	NNP	_	_	14	NAME	_	_
14	Sherblom	_	NNP	_	_	11	SBJ	_	_
15	,	_	,	_	_	14	P	_	_
16	Transgenic	_	NNP	_	_	18	NMOD	_	_
17	's	_	POS	_	_	16	SUFFIX	_	_
18	chairman	_	NN	_	_	14	APPO	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	chief	_	JJ	_	_	22	NMOD	_	_
21	executive	_	NN	_	_	22	NMOD	_	_
22	officer	_	NN	_	_	19	CONJ	_	_
23	.	_	.	_	_	11	P	_	_

